Clinical Trial: Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07138287) titled 'Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.' on July 10.

Brief Summary: Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis

Study Start Date: July 11

Study Type: INTERVENTIONAL

Condition: Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis

Intervention: PROCEDURE: Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

Concerned Growth fact...